Performance Review Board Members, 50665 [2018-21855]

Download as PDF Federal Register / Vol. 83, No. 195 / Tuesday, October 9, 2018 / Notices A copy of the COGME charter is available on the COGME website at: https://www.hrsa.gov/advisorycommittees/graduate-medical-edu/ index.html. A copy of the charter can also be obtained by accessing the FACA database that is maintained by the Committee Management Secretariat under the General Services Administration. The website for the FACA database is http:// www.facadatabase.gov/. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–21864 Filed 10–5–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Performance Review Board Members Title 5, U.S.C. Section 4314(c)(4) of the Civil Service Reform Act of 1978, Public Law 95–454, requires that the appointment of Performance Review Board Members be published in the Federal Register. The following persons may be named to serve on the Performance Review Boards or Panels, which oversee the evaluation of performance appraisals of Senior Executive Service members of the Department of Health and Human Services. Employee last name amozie on DSK3GDR082PROD with NOTICES1 Barry .......................... Brady ......................... Brown ........................ Coquis ....................... Fantinato ................... Fischmann ................. Gentile ....................... Goldhaber ................. Hargan ...................... Haseltine ................... Kretschmaier ............. Lewis ......................... McDaniel ................... Novy .......................... Rowell ....................... Sample ...................... Skeadas .................... Tobias ....................... Employee first name Daniel William Mark Roberto Jessica Elizabeth John Ben Eric Amy Michon Lisa Eileen Steve Scott Allen Christos Constance Dated: October 1, 2018. Charles H. McEnerney III, Director, Executive and Scientific Resources Division. [FR Doc. 2018–21855 Filed 10–5–18; 8:45 am] BILLING CODE 4151–17–P VerDate Sep<11>2014 19:13 Oct 05, 2018 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Clinical Care Commission Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The National Clinical Care Commission (the Commission) will conduct its inaugural meeting on October 31, 2018. The Commission will evaluate and make recommendations to the U.S. Department of Health and Human Services (HHS) Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to awareness and clinical care for complex metabolic or autoimmune diseases that result from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases. DATES: The meeting will take place on October 31, 2018, from 8:00 a.m. to approximately 5:00 p.m. Eastern Time (ET). ADDRESSES: National Institutes of Health, Building 35, John Edward Porter Neuroscience Research Center [PNRC II], 35 Convent Drive, Bethesda, MD 20892. The meeting will also be held online via webcast. To register to attend the meeting, please visit the registration website at https:// events.kauffmaninc.com/events/ ncccmeetingone/. FOR FURTHER INFORMATION CONTACT: Clydette Powell, Designated Federal Official, National Clinical Care Commission, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Suite LL–100, Rockville, MD 20852. Email: OHQ@hhs.gov. Additional information may be obtained at https:// health.gov/hcq/national-clinical-carecommission.asp. SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act (Pub. L. 115–80) requires the HHS Secretary to establish the National Clinical Care Commission. The Commission will consist of representatives of specific federal agencies and non-federal individuals and entities who represent diverse disciplines and views. The Commission will evaluate and make recommendations to the HHS Secretary SUMMARY: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 50665 and Congress regarding improvements to the coordination and leveraging of federal programs related to awareness and clinical care for complex metabolic or autoimmune diseases that result from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases. This inaugural meeting of the Commission will consist of swearing-in non-federal Commission members, an overview of various federal interagency efforts surrounding diabetes programs, the establishment of the Commission subcommittee structure, and setting future agenda topics. The names and biographies of the Commission members and final meeting agenda will be available prior to the meeting at https:// health.gov/hcq/national-clinical-carecommission.asp. Public Participation at Meeting: The Commission invites public comment on issues related to the Commission’s charge either in-person at the meeting or in writing. In-person attendees who plan to provide oral comments at the Commission meeting during a designated time must submit their comments to OHQ@hhs.gov on or before October 24, 2018 and must check-in onsite. To accommodate as many individuals as possible, the time for each comment will be limited to three minutes. If more requests are received than can be accommodated, speakers will be randomly selected. The nature of the comments will not be considered in making this selection. Written comments are welcome throughout the entire development process of the Commission and may be emailed to OHQ@hhs.gov, or by mail to the following address: Public Commentary, National Clinical Care Commission, 1101 Wootton Parkway, Suite LL–100, Rockville, MD 20852. Written comments should not exceed three pages in length. To attend the Commission meeting, individuals must pre-register at the registration website at https:// events.kauffmaninc.com/events/ ncccmeetingone/. In-person and live videocast attendance options are available. In-person attendance at the meeting is limited to space available. Inperson registrations will be accepted until maximum capacity is reached and must be completed by October 25, 2018. On the day of the meeting, seating will be provided first to persons who have pre-registered. Those who have not preregistered will be accommodate on a first come, first served basis if additional seats are still available 10 minutes before the meeting start. Individuals who need special assistance, such as sign language E:\FR\FM\09OCN1.SGM 09OCN1

Agencies

[Federal Register Volume 83, Number 195 (Tuesday, October 9, 2018)]
[Notices]
[Page 50665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21855]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Performance Review Board Members

    Title 5, U.S.C. Section 4314(c)(4) of the Civil Service Reform Act 
of 1978, Public Law 95-454, requires that the appointment of 
Performance Review Board Members be published in the Federal Register.
    The following persons may be named to serve on the Performance 
Review Boards or Panels, which oversee the evaluation of performance 
appraisals of Senior Executive Service members of the Department of 
Health and Human Services.

------------------------------------------------------------------------
            Employee  last name                 Employee  first name
------------------------------------------------------------------------
Barry.....................................  Daniel
Brady.....................................  William
Brown.....................................  Mark
Coquis....................................  Roberto
Fantinato.................................  Jessica
Fischmann.................................  Elizabeth
Gentile...................................  John
Goldhaber.................................  Ben
Hargan....................................  Eric
Haseltine.................................  Amy
Kretschmaier..............................  Michon
Lewis.....................................  Lisa
McDaniel..................................  Eileen
Novy......................................  Steve
Rowell....................................  Scott
Sample....................................  Allen
Skeadas...................................  Christos
Tobias....................................  Constance
------------------------------------------------------------------------


    Dated: October 1, 2018.
Charles H. McEnerney III,
Director, Executive and Scientific Resources Division.
[FR Doc. 2018-21855 Filed 10-5-18; 8:45 am]
 BILLING CODE 4151-17-P